Targeted therapy in thyroid cancer: molecular alterations and clinical management - Top-Institutions - MDSpire

Targeted therapy in thyroid cancer: molecular alterations and clinical management

  • By

  • YiHeng Yang

  • YeSheng Zhang

  • YongCan Xu

  • XiaoXin Gu

  • Neng Lou

  • GuoChao Ye

  • June 5, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Emory University
    Emory University

    Atlanta, GA

    Key Differentiators

    • Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

Original Source(s)

Targeted therapy in thyroid cancer: molecular alterations and clinical management

  • by YiHeng Yang, YeSheng Zhang, YongCan Xu, XiaoXin Gu, Neng Lou, GuoChao Ye

  • June 5, 2026

Related Content

Multidisciplinary treatment of follicular thyroid carcinoma with hepatic and pulmonary metastases: a case report and literature review

Multiple primary head and neck cancers: a scenario-based framework for diagnosis and modern multidisciplinary management

Beyond prediction: AI as a mechanistic microscope and digital twin for colorectal cancer immunotherapy